In this issue:
PVd superior to Vd at first relapse regardless of lenalidomide-refractory status
Longer duration post-ASCT lenalidomide maintenance confers improved outcomes
Could rapid reduction of iFLCs be prognostic in patients receiving front-line BPV?
Front-line bortezomib increases the risk of falls and death in older adults
Involved FLC is an early independent predictor of response and progression
HOVON 143: IDd induces high response rates in frail patients
Localised radiotherapy before and during induction delays stem cell mobilisation and collection
Significant reduction in late mortality in patients who undergo an autologous transplant
Trajectory of symptoms in patients undergoing autologous transplant
Targeting Tregs is a novel potential therapeutic option in MM
Please login below to download this issue (PDF)